NYSE:WAT Waters (WAT) Stock Price, News & Analysis $342.83 +0.46 (+0.13%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$343.54 +0.71 (+0.21%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Waters Stock (NYSE:WAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Waters alerts:Sign Up Key Stats Today's Range$338.00▼$346.5750-Day Range$283.58▼$355.1252-Week Range$275.05▼$414.15Volume477,982 shsAverage Volume1.19 million shsMarket Capitalization$33.66 billionP/E Ratio43.56Dividend YieldN/APrice Target$396.00Consensus RatingModerate Buy Company Overview Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses. Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers. The company operates through a global sales and service network, supporting customers across the Americas, Europe, Asia-Pacific and other international markets with regional offices, distribution partners and application support teams. Founded in 1958, Waters has a history as a specialist in separation and analytical science and has been publicly traded on the New York Stock Exchange. Headquartered in Milford, Massachusetts, the company emphasizes innovation in instrumentation and informatics and pairs product sales with laboratory services and consumables to provide end-to-end analytical solutions. Waters’ ongoing focus is on enabling more precise, reliable and efficient analytical workflows for regulated and research environments worldwide.AI Generated. May Contain Errors. Read More Waters Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreWAT MarketRank™: Waters scored higher than 87% of companies evaluated by MarketBeat, and ranked 108th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingWaters has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 strong buy ratings, 9 buy ratings, 8 hold ratings, and no sell ratings.Upside PotentialWaters has a consensus price target of $396.00, representing about 15.5% upside from its current price of $342.83.Amount of Analyst CoverageWaters has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Waters' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth13.86% Earnings GrowthEarnings for Waters are expected to grow by 13.86% in the coming year, from $14.50 to $16.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Waters is 43.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Waters is 43.56, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.00.Price to Earnings Growth RatioWaters has a PEG Ratio of 2.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioWaters has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Waters' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.50% of the float of Waters has been sold short.Short Interest Ratio / Days to CoverWaters has a short interest ratio ("days to cover") of 3.55, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Waters has recently decreased by 8.11%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWaters does not currently pay a dividend.Dividend GrowthWaters does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.60 News SentimentWaters has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Waters this week, compared to 11 articles on an average week.Search InterestOnly 9 people have searched for WAT on MarketBeat in the last 30 days. This is a decrease of -36% compared to the previous 30 days.MarketBeat Follows2 people have added Waters to their MarketBeat watchlist in the last 30 days. Company Ownership2.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Waters insiders have bought more of their company's stock than they have sold. Specifically, they have bought $144,730.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.31% of the stock of Waters is held by insiders.Percentage Held by Institutions94.01% of the stock of Waters is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Waters' insider trading history. Receive WAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WAT Stock News HeadlinesNew Waterside Getaways for the Summer3 hours ago | nytimes.comWaters Corporation: Performing Better Than ExpectedMay 22 at 11:31 AM | seekingalpha.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.May 25 at 1:00 AM | Profits Run (Ad)Fundraising Update: Representative Maxine Waters just disclosed $126.2K of new fundraisingMay 22 at 10:10 AM | quiverquant.comQWaters Corporation to Present at the Jefferies Global Healthcare ConferenceMay 18, 2026 | prnewswire.comWells Fargo & Company Issues Positive Forecast for Waters (NYSE:WAT) Stock PriceMay 15, 2026 | americanbankingnews.comWhat Makes Waters Corporation (WAT) an Investment Bet?May 11, 2026 | finance.yahoo.comWaters Corporation 2026 Q1 - Results - Earnings Call PresentationMay 7, 2026 | seekingalpha.comSee More Headlines WAT Stock Analysis - Frequently Asked Questions How have WAT shares performed this year? Waters' stock was trading at $380.45 at the beginning of the year. Since then, WAT shares have decreased by 9.9% and is now trading at $342.8260. How were Waters' earnings last quarter? Waters Corporation (NYSE:WAT) posted its quarterly earnings results on Tuesday, May, 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters's quarterly revenue was up 91.4% on a year-over-year basis. Read the conference call transcript. Does Waters have any subsidiaries? The following companies are subsidiaries of Waters: Andrew Alliance S.A, Andrew Alliance, Rubotherm, MPE Orbur Group Ltd. (UK), ElectroForce, Blue Reference Inc., Baehr Thermoanalyse GmbH, and more. Who are Waters' major shareholders? Top institutional shareholders of Waters include Janus Henderson Group PLC (1.67%), Principal Financial Group Inc. (1.04%), Bank of America Corp DE (0.86%) and Dimensional Fund Advisors LP (0.83%). Insiders that own company stock include Christopher A Kuebler, Wei Jiang, Linda Baddour and Richard H Fearon. View institutional ownership trends. How do I buy shares of Waters? Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Waters own? Based on aggregate information from My MarketBeat watchlists, some other companies that Waters investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings5/05/2026Today5/25/2026Jefferies Global Healthcare Conference 20266/03/2026Next Earnings (Estimated)8/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 WAT's financial health is in the Red zone, according to TradeSmith. WAT has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:WAT CIK1000697 Webwww.waters.com Phone(508) 478-2000Fax508-872-1990Employees7,900Year Founded1958Price Target and Rating Average Price Target for Waters$396.00 High Price Target$480.00 Low Price Target$345.00 Potential Upside/Downside+15.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage20 Analysts Profitability EPS (Trailing Twelve Months)$7.87 Trailing P/E Ratio43.56 Forward P/E Ratio23.64 P/E Growth2.16Net Income$642.63 million Net Margins11.91% Pretax Margin13.89% Return on Equity15.60% Return on Assets8.90% Debt Debt-to-Equity Ratio0.32 Current Ratio1.79 Quick Ratio1.13 Sales & Book Value Annual Sales$3.77 billion Price / Sales8.93 Cash Flow$16.65 per share Price / Cash Flow20.59 Book Value$155.74 per share Price / Book2.20Miscellaneous Outstanding Shares98,186,000Free Float97,882,000Market Cap$33.66 billion OptionableOptionable Beta1.14 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:WAT) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waters Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Waters With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
